These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7055010)

  • 1. Pharmacology of arteriovenous anastomoses.
    Spierings EL; Saxena PR
    Adv Neurol; 1982; 33():291-4. PubMed ID: 7055010
    [No Abstract]   [Full Text] [Related]  

  • 2. Arteriovenous shunting and migraine.
    Saxena PR
    Res Clin Stud Headache; 1978; 6():89-102. PubMed ID: 725261
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.
    den Boer MO; Somers JA; Saxena PR
    Br J Pharmacol; 1992 Oct; 107(2):577-83. PubMed ID: 1330188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of isometheptene on the distribution and shunting of 15 microM microspheres throughout the cephalic circulation of the cat.
    Spierings EL; Saxena PR
    Headache; 1980 Mar; 20(2):103-6. PubMed ID: 7372473
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimigraine drugs and cranial arteriovenous shunting in the cat.
    Spierings EL; Saxena PR
    Neurology; 1980 Jul; 30(7 Pt 1):696-701. PubMed ID: 7190237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ergotamine on cranial arteriovenous shunting in experiments with constant flow perfusion.
    Spierings EL; Saxena PR
    Eur J Pharmacol; 1979 Jun; 56(1-2):31-7. PubMed ID: 467512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification, pathogenesis and drug therapy of migraine and related forms of headache].
    Fanchamps A
    Med Welt; 1975 Aug; 6(35):1518-23. PubMed ID: 241000
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
    Lance JW; Spira PJ; Mylecharane EJ; Lord GD; Duckworth JW
    Res Clin Stud Headache; 1978; 6():13-8. PubMed ID: 103151
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey.
    Spira PJ; Mylecharane EJ; Lance JW
    Res Clin Stud Headache; 1976; 4():37-75. PubMed ID: 818690
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine.
    Saxena PR; de Vlaam-Schluter GM
    Headache; 1974 Jan; 13(4):142-63. PubMed ID: 4149297
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD
    Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The animal pharmacology of drugs used in the treatment of migraine.
    Fozard JR
    J Pharm Pharmacol; 1975 May; 27(5):297-321. PubMed ID: 239131
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of action of drugs currently used in the prevention of migraine].
    Fanchamps A
    Minerva Med; 1976 Jun; 67(28):1858-60. PubMed ID: 59325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of ergotamine on the distribution of carotid blood flow--the migraine shunt theory revisited.
    Spierings EL; Saxena PR
    Headache; 1980 May; 20(3):143-5. PubMed ID: 7390796
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors.
    Bom AH; Heiligers JP; Saxena PR; Verdouw PD
    Br J Pharmacol; 1989 Jun; 97(2):383-90. PubMed ID: 2758221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of ergot alkaloids in clinical use.
    Berde B
    Med J Aust; 1978 Nov; 2(3 Suppl):3-13. PubMed ID: 370528
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Hardebo JE; Edvinsson L; Owman C; Svendgaard NA
    Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurovascular pharmacology of migraine.
    Maassenvandenbrink A; Chan KY
    Eur J Pharmacol; 2008 May; 585(2-3):313-9. PubMed ID: 18423447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ergotamine and methysergide as serotonin partial agonists in migraine.
    Fanciullacci M; Granchi G; Sicuteri F
    Headache; 1976 Nov; 16(5):226-31. PubMed ID: 977328
    [No Abstract]   [Full Text] [Related]  

  • 20. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
    Goadsby PJ; Edvinsson L
    Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.